Four and Half Lim Protein 2 (FHL2) stimulates osteoblast differentiation

Journal of Bone and Mineral Research

Volumn 21, Issue 1, 2006, Pages 17-28

  Lai, Chung Fang ^a   Bai, Shuting ^a   Uthgenannt, Brian A ^a   Halstead, Linda R ^a   McLoughlin, Patricia ^b   Schafer, Beat W ^b   Chu, Po Hsien ^c,d   Chen, Ju ^c   Otey, Carol A ^e   Cao, Xu ^f   Cheng, Su Li ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f University of Alabama at Birmingham   (United States)

Author keywords

Body composition; Differentiation; Four and Half Lim Protein; Integrins; Osteoblasts

Indexed keywords

ACTIN BINDING PROTEIN; ALIZARIN RED S; ALKALINE PHOSPHATASE; ALPHAVBETA5 INTEGRIN; ARGINYLGLYCYLASPARTYLSERINE; BETA5 INTEGRIN; BIOLOGICAL MARKER; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FILAMIN A; FOUR AND HALF LIM PROTEIN 2; INTEGRIN; LIM PROTEIN; MESSENGER RNA; PALLADIN; PROTEIN SUBUNIT; SCLEROPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MSX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL NUCLEUS; CELL STIMULATION; COLONY FORMATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; ENZYME ACTIVITY; FOCAL ADHESION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MORPHOMETRICS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; OVARIECTOMY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RNA ANALYSIS; SIGNAL TRANSDUCTION; STAINING; TWO HYBRID SYSTEM; WESTERN BLOTTING; WILD TYPE; YEAST;

ANIMALS; ANTIGENS, DIFFERENTIATION; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELLS, CULTURED; DNA-BINDING PROTEINS; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; INTEGRINS; MICE; MICE, KNOCKOUT; MUSCLE PROTEINS; OSTEOBLASTS; OSTEOGENESIS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 29644441338     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.050915     Document Type: Article

References (63)

1. Bennett JH, Moffatt S, Horton M 2001 Cell adhesion molecules in human osteoblasts: Structure and function. Histol Histopathol 16:603-611.
2. Damsky CH 1999 Extracellular matrix-integrin interactions in osteoblast function and tissue remodeling. Bone 25:95-96.
3. Gronthos S, Simmons PJ, Graves SE, Robey PG 2001 Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix. Bone 28:174-181.
4. Grzesik WJ, Robey PG 1994 Bone matrix RGD glycoproteins: Immunolocalization and interaction with human primary osteoblastic bone cells in vitro. J Bone Miner Res 9:487-496.
5. Oldberg A, Franzen A, Heinegard D, Pierschbacher M, Ruoslahti E 1988 Identification of a bone sialoprotein receptor in osteosarcoma cells. J Biol Chem 263:19433-19436.
6. Lai CF, Cheng SL 2005 Alphavbeta integrins play an essential role in BMP-2 induction of osteoblast differentiation. J Bone Miner Res 20:330-340.
7. Huang X, Griffiths M, Wu J, Farese RV Jr, Sheppard D 2000 Normal development, wound healing, and adenovirus susceptibility in beta5-deficient mice. Mol Cell Biol 20:755-759.
8. Green LJ, Mould AP, Humphries MJ 1998 The integrin beta subunit. Int J Biochem Cell Biol 30:179-184.
9. Chan KK, Tsui SK, Lee SM, Luk SC, Liew CC, Fung KP, Waye MM, Lee CY 1998 Molecular cloning and characterization of FHL2, a novel LIM domain protein preferentially expressed in human heart. Gene 210:345-350.
10. Genini M, Schwalbe P, Scholl FA, Remppis A, Mattei MG, Schafer BW 1997 Subtractive cloning and characterization of DRAL, a novel LIM-domain protein down-regulated in rhabdomyosarcoma. DNA Cell Biol 16:433-442.
11. Bach I 2000 The LIM domain: Regulation by association. Mech Dev 91:5-17.
12. Wixler V, Geerts D, Laplantine E, Westhoff D, Smyth N, Aumailley M, Sonnenberg A, Paulsson M 2000 The LIM-only protein DRAL/FHL2 binds to the cytoplasmic domain of several alpha and beta integrin chains and is recruited to adhesion complexes. J Biol Chem 275:33669-33678.
13. Samson T, Smyth N, Janetzky S, Wendler O, Muller JM, Schule R, Von-Der MH, Von-Der MK, Wixler V 2004 The LIM-only proteins FHL2 and FHL3 interact with alpha- and beta-subunits of the muscle alpha 7beta 1 integrin receptor. J Biol Chem 279:28641-28652.
14. Purcell NH, Darwis D, Bueno OF, Muller JM, Schule R, Molkentin JD 2004 Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes. Mol Cell Biol 24:1081-1095.
15. Muller JM, Metzger E, Greschik H, Bosserhoff AK, Mercep L, Buettner R, Schule R 2002 The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus. EMBO J 21:736-748.
16. Fimia GM, De Cesare D, Sassone-Corsi P 2000 A family of LIM-only transcriptional coactivators: Tissue-specific expression a nd selective activation of CREB and CREM. Mol Cell Biol 20:8613-8622.
17. Johannessen M, Olsen PA, Johansen B, Seternes OM, Moens U 2003 Activation of the coactivator four-and-a-half-LIM-only protein FHL2 and the c-fos promoter through inhibition of protein phosphatase 2A. Biochem Pharmacol 65:1317-1328.
18. Martin B, Schneider R, Janetzky S, Waibler Z, Pandur P, Kuhl M, Behrens J, Von Der MK, Starzinski-Powitz A, Wixler V 2002 The LIM-only protein FHL2 interacts with beta-catenin and promotes differentiation of mouse myoblasts. J Cell Biol 159:113-122.
19. Morlon A, Sassone-Corsi P 2003 The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1. Proc Natl Acad Sci USA 100:3977-3982.
20. Muller JM, Isele U, Metzger E, Rempel A, Moser M, Pscherer A, Breyer T, Holubarsch C, Buettner R, Schule R 2000 FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO J 19:359-369.
21. Wei Y, Renard CA, Labalette C, Wu Y, Levy L, Neuveut C, Prieur X, Flajolet M, Prigent S, Buendia MA 2003 Identification of the LIM protein FHL2 as a coactivator of beta-catenin. J Biol Chem 278:5188-5194.
22. Labalette C, Renard CA, Neuveut C, Buendia MA, Wei Y 2004 Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin. Mol Cell Biol 24:10689-10702.
23. McLoughlin P, Ehler E, Carlile G, Licht JD, Schafer BW 2002 The LIM-only protein DRAL/FHL2 interacts with and is a corepressor for the promyelocytic leukemia zinc finger protein. J Biol Chem 277:37045-37053.
24. Chen D, Xu W, Bales E, Colmenares C, Conacci-Sorrell M, Ishii S, Stavnezer E, Campisi J, Fisher DE, Ben Ze'ev A, Medrano EE 2003 SKI activates Wnt/beta-catenin signaling in human melanoma. Cancer Res 63:6626-6634.
25. Scholl FA, McLoughlin P, Ehler E, de Giovanni C, Schafer BW 2000 DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis. J Cell Biol 151:495-506.
26. Amaar YG, Thompson GR, Linkhart TA, Chen ST, Baylink DJ, Mohan S 2002 Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2). J Biol Chem 277:12053-12060.
27. Cheng SL, Lai CF, Fausto A, Chellaiah M, Feng X, McHugh KP, Teitelbaum SL, Civitelli R, Hruska KA, Ross FP, Avioli LV 2000 Regulation of alphaVbeta3 and alphaVbeta5 integrins by dexamethasone in normal human osteoblastic cells. J Cell Biochem 77:265-276.
28. Cheng SL, Lecanda F. Davidson MK, Warlow PM, Zhang SF, Zhang L, Suzuki S, St John T, Civitelli R 1998 Human osteoblasts express a repertoire of cadherins, which are critical for BMP-2-induced osteogenic differentiation. J Bone Miner Res 13:633-644.
29. Lai CF, Chaudhary L, Fausto A, Halstead LR, Ory DS, Avioli LV, Cheng SL 2001 Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J Biol Chem 276:14443-14450.
30. Feng X, Teitelbaum SL, Quiroz ME, Cheng SL, Lai CF, Avioli LV, Ross FP 2000 Sp1/Sp3 and PU.1 differentially regulate beta(5) integrin gene expression in macrophages and osteoblasts. J Biol Chem 275:8331-8340.
31. Cheng SL, Zhang SF, Nelson TL, Warlow PM, Civitelli R 1994 Stimulation of human osteoblast differentiation and function by ipriflavone and its metabolites. Calcif Tissue Int 55:356-362.
32. Chu PH, Bardwell WM, Gu Y, Ross J Jr, Chen J 2000 FHL2 (SLIM3) is not essential for cardiac development and function. Mol Cell Biol 20:7460-7462.
33. Castro CH, Shin CS, Stains JP, Cheng SL, Sheikh S, Mbalaviele G, Szejnfeld VL, Civitelli R 2004 Targeted expression of a dominant-negative N-cadherin in vivo delays peak bone mass and increases adipogenesis. J Cell Sci 117:2853-2864.
34. Parast MM, Otey CA 2000 Characterization of palladin, a novel protein localized to stress fibers and cell adhesions. J Cell Biol 150:643-656.
35. Ronty M, Taivainen A, Moza M, Otey CA, Carpen O 2004 Molecular analysis of the interaction between palladin and alpha-actinin. FEBS Lett 566:30-34.
36. van der FA, Sonnenberg A 2001 Structural and functional aspects of filamins. Biochim Biophys Acta 1538:99-117.
37. Gronthos S, Stewart K, Graves SE, Hay S, Simmons PJ 1997 Integrin expression and function on human osteoblast-like cells. J Bone Miner Res 12:1189-1197.
38. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, Parsons JT, Horwitz AR 2003 Cell migration: Integrating signals from front to back. Science 302:1704-1709.
39. Ruoslahti E, Pierschbacher MD 1987 New perspectives in cell adhesion: RGD and integrins. Science 238:491-497.
40. Cheng SL, Shao JS, Charlton-Kachigian N, Loewy AP, Towler DA 2003 MSX2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. J Biol Chem 278:45969-45977.
41. Chu PH, Ruiz-Lozano P, Zhou Q, Cai C, Chen J 2000 Expression patterns of FHL/SLIM family members suggest important functional roles in skeletal muscle and cardiovascular system. Mech Dev 95:259-265.
42. Richman C, Baylink DJ, Lang K, Dony C, Mohan S 1999 Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo. Endocrinology 140:4699-4705.
43. Ng EK, Chan KK, Wong CH, Tsui SK, Ngai SM, Lee SM, Kotaka M, Lee CY, Waye MM, Fung KP 2002 Interaction of the heart-specific LIM domain protein, FHL2, with DNA-binding nuclear protein, hNP220. J Cell Biochem 84:556-566.
44. Li HY, Kotaka M, Kostin S, Lee SM, Kok LD, Chan KK, Tsui SK, Schaper J, Zimmermann R, Lee CY, Fung KP, Waye MM 2001 Translocation of a human focal adhesion LIM-only protein, FHL2, during myofibrillogenesis and identification of LIM2 as the principal determinants of FHL2 focal adhesion localization. Cell Motil Cytoskeleton 48:11-23.
45. Gabriel B, Mildenberger S, Weisser CW, Metzger E, Gitsch G, Schule R, Muller JM 2004 Focal adhesion kinase interacts with the transcriptional coactivator FHL2 and both are overexpressed in epithelial ovarian cancer. Anticancer Res 24:921-927.
46. Hofbauer LC, Khosla S 1999 Androgen effects on bone metabolism: Recent progress and controversies. Eur J Endocrinol 140:271-286.
47. Kousteni S, Han L, Chen JR, Almeida M, Plotkin LI, Bellido T, Manolagas SC 2003 Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids. J Clin Invest 111:1651-1664.
48. Manolagas SC, Kousteni S, Jilka RL 2002 Sex steroids and bone. Recent Prog Horm Res 57:385-409.
49. Ogasawara A, Arakawa T, Kaneda T, Takuma T, Sato T, Kaneko H, Kumegawa M, Hakeda Y 2001 Fluid shear stress-induced cyclooxygenase-2 expression is mediated by C/EBP beta, cAMP-response element-binding protein, and AP-1 in osteoblastic MC3T3-E1 cells. J Biol Chem 276:7048-7054.
50. Samoto H, Shimizu E, Matsuda-Honjyo Y, Saito R, Nakao S, Yamazaki M, Furuyama S, Sugiya H, Sodek J, Ogata Y 2003 Prostaglandin E2 stimulates bone sialoprotein (BSP) expression through cAMP and fibroblast growth factor 2 response elements in the proximal promoter of the rat BSP gene. J Biol Chem 278:28659-28667.
51. Westendorf JJ, Kahler RA, Schroeder TM 2004 Wnt signaling in osteoblasts and bone diseases. Gene 341:19-39.
52. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B 2002 The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108:17-29.
53. Lee MH, Kwon TG, Park HS, Wozney JM, Ryoo HM 2003 BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Res Commun 309:689-694.
54. Hussein SM, Duff EK, Sirard C 2003 Smad4 and beta-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2. J Biol Chem 278:48805-48814.
55. Etienne-Manneville S, Hall A 2002 Rho GTPases in cell biology. Nature 420:629-635.
56. Hall A 1998 Rho GTPases and the actin cytoskeleton. Science 279:509-514.
57. Balint E. Lapointe D, Drissi H, Vander MC, Young DW, Vanwijnen AJ, Stein JL, Stein GS, Lian JB 2003 Phenotype discovery by gene expression profiling: Mapping of biological processes linked to BMP-2-mediated osteoblast differentiation. J Cell Biochem 89:401-426.
58. Nakazawa T, Nakajima A, Seki N, Okawa A, Kato M, Moriya H, Amizuka N, Einhorn TA, Yamazaki M 2004 Gene expression of periostin in the early stage of fracture healing detected by cDNA microarray analysis. J Orthop Res 22:520-525.
59. Gunther T, Poli C, Muller JM, Catala-Lehnen P, Schinke T, Yin N, Vomstein S, Amling M, Schule R 2005 Fhl2 deficiency results in osteopenia due to decreased activity of osteoblasts. EMBO J 24:3049-3056.
60. Bouxsein ML, Myers KS, Shultz KL, Donahue LR, Rosen CJ, Beamer WG 2005 Ovariectomy-induced bone loss varies among inbred strains of mice. J Bone Miner Res 20:1085-1092.
61. Turner CH, Hsieh YF, Muller R, Bouxsein ML, Baylink DJ, Rosen CJ, Grynpas MD, Donahue LR, Beamer WG 2000 Genetic regulation of cortical and trabecular bone strength and microstructure in inbred strains of mice. J Bone Miner Res 15:1126-1131.
62. Akhter MP, Fan Z, Rho JY 2004 Bone intrinsic material properties in three inbred mouse strains. Calcif Tissue Int 75:416-420.
63. Beamer WG, Donahue LR, Rosen CJ, Baylink DJ 1996 Genetic variability in adult bone density among inbred strains of mice. Bone 18:397-403.